3 Stocks Cathie Wood Is Buying That Should Be on Your List Too

Cathie Wood’s investments continue to focus on innovation, but the popular investor hasn’t forgotten to find a great deal as well!

| More on:
Workers use a microscope to do medical research in a modern laboratory.

Source: Getty Images

Many Canadian investors are likely already familiar with Warren Buffett. However, you may not be as familiar with Cathie Wood. Cathie Wood is also one of the most popular investment strategists in the United States. And it’s why we turn our attention to Cathie Wood and her ARK Invest company.

Today, we’re going to look at the companies that Cathie Wood has been buying these days. Ones that show signs of strong innovation, which Cathie Wood focuses on, and why even Canadian investors can get in on this action.

CRISPR

First up we have CRISPR Therapeutics (NASDAQ:CRSP), a healthcare company with a focus on gene editing. Yet in recent history, Cathie Wood is likely interested in the stock as an acquisition target. This comes after approval of Casgevy, a one-time treatment for sickle cell disease. And this could generate incredible revenue in the near future.

Yet the stock is down from all-time highs, with revenue shrinking in the recent past. Because of this, it could be a valuable acquisition target for the right buyer – and, therefore, an easy way to get in on the gene editing market.

As for today’s investor, it’s a great time to get in on CRISPR stock. It’s already on the path to recovery, has a solid future ahead with its Casgevy product, and could be part of an acquisition. Shares are up 24% in the last year alone, with even more growth ahead to help it reach its 52-week high.

Recursion

Another top stock in the healthcare sector that Cathie Wood is buying is Recursion Pharmaceuticals (NASDAQ:RXRX). This TechBio company has spent a decade “building one of the world’s largest biological and chemical datasets,” the company states. This will help future scientists “decode biology” and allow for a faster way of identifying the right solution to improve drug efficiency.

Recursion, however, recently outlined its new Large Language Model-Orchestrated Workflow Engine (LOWE), which is like artificial intelligence (AI) for biology and chemical data. With a faster workflow, the company can make faster discoveries, and therefore sell drugs faster. So no wonder shares have soared higher and higher.

However, this of course takes a lot of investment. The company continues to trade at a loss, with revenues expected to continue to be lower than in previous years. Even so, long-term investors such as Cathie Wood will likely see great things from this stock. For now, shares are still up by an impressive 22% in the last year.

Unity

Canadian investors can also check out Unity Software (NYSE:U) for something out of the healthcare sector. Cathie Wood recently invested in the game engine, despite going through quite a bit of drama over the last while. Unity stock cut 25% of its workforce during a company “restructure,” just last week. All while the stock continues to spiral.

However, it seems that Cathie Wood is using this spiral as an opportunity. Especially as an interm-chief executive officer (CEO) stepped in from IBM, and was already making changes. Specifically, the interm-CEO stated the company is trying to do too many things.

It’s unclear where the focus will be in the near future. And that focus likely won’t happen until Unity has a full-time CEO. But for now, investors such as Cathie Wood are taking this downturn as an opportunity ahead of what could be a huge turnaround in the future. Especially from an innovative company like Unity stock.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Amy Legate-Wolfe has no position in any of the stocks mentioned. The Motley Fool recommends CRISPR Therapeutics, International Business Machines, and Unity Software. The Motley Fool has a disclosure policy.

More on Tech Stocks

nvidia headquarters with nvidia sign in front
Tech Stocks

Why Nvidia Stock Surged After the Fed Rate Cut

An interest rate cut can be a growth stimulant for a variety of businesses in the market, including semiconductor giants.

Read more »

top TSX stocks to buy
Tech Stocks

2 Stocks That Could Transform $100,000 Into $1 Million

To become a millionaire, you need to harness the power of compounding by staying invested for a longer term in…

Read more »

online shopping
Tech Stocks

PayFare Stock: Can This Undervalued Stock Make You a Millionaire One Day?

These hidden gems provide opportunities to buy low and, hopefully, sell high.

Read more »

The virtual button with the letters AI in a circle hovering above a keyboard, about to be clicked by a cursor.
Tech Stocks

2 Beaten-Down AI Stocks Every Canadian Investor Should Watch

Investors with a high risk appetite can consider investing in AI stocks such as UiPath and Hive to benefit from…

Read more »

TFSA and coins
Tech Stocks

Here’s the Average TFSA Balance in 2024

Here's why investors should hold quality stocks such as Microsoft in their TFSA and benefit from outsized gains in 2024…

Read more »

think thought consider
Tech Stocks

What’s Going on With Kinaxis Stock?

Kinaxis stock looks like a solid long-term option and may already have some growth momentum that investors need to watch.

Read more »

edit Business accounting concept, Business man using calculator with computer laptop, budget and loan paper in office.
Tech Stocks

BlackBerry Is a Top Stock to Buy Right Now, But Only if You Believe This 1 Thing

BlackBerry’s increased focus on AI and machine learning-based software solutions could immensely boost its financial growth trends in the long…

Read more »

Shopping and e-commerce
Tech Stocks

Is Shopify Stock a No-Brainer Buy?

Despite Shopify’s (TSX:SHOP) strong financial growth trends and solid long-term growth fundamentals, its stock’s recent underperformance makes it even more…

Read more »